Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
Clarithromycin
hameln pharma gmbh
J01FA09
Clarithromycin
500 milligram(s)
Powder for concentrate for solution for infusion
clarithromycin
Not marketed
2021-03-19
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CLARITHROMYCIN 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION clarithromycin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Clarithromycin is and what it is used for 2. What you need to know before you are given Clarithromycin 3. How Clarithromycin is given 4. Possible side effects 5. How to store Clarithromycin 6. Contents of the pack and other information 1. WHAT CLARITHROMYCIN IS AND WHAT IT IS USED FOR Clarithromycin contains the active ingredient clarithromycin. Clarithromycin belongs to a group of medicines called macrolide antibiotics. Antibiotics stop the growth of bacteria (bugs) that cause infections. Clarithromycin is used whenever an intravenous (injection into the vein) antibiotic is required to treat severe infections or, alternatively, if a patient cannot swallow tablets. It is used to treat infections caused by bacteria such as: 1. A flare-up of chronic bronchitis and infection of the lungs (pneumonia) 2. Severe infection of the sinuses (sinusitis), throat (pharyngitis) and tonsils (tonsillitis) 3. Skin and tissue infections Clarithromycin is used in adults and children 12 years and older. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN CLARITHROMYCIN CLARITHROMYCIN MUST NOT BE GIVEN : − if you are allergic to clarithromycin, other macrolide antibiotics such as erythromycin or azithromycin, or any of the other ingredients of this medicine (listed in section 6). − if you are taking medicines called ergot alkaloid tablets (e.g. ergotamine or dihydroergotamine) or use ergotamine inhalers for migraine. − if you are taking medicines called terfenadine or astemizole (widely take Perskaitykite visą dokumentą
Health,Products,Regulatory,Authority 25,November,2022 CRN00D37Q Page,1,of,15 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clarithromycin,500,mg,powder,for,concentrate,for,solution,for,infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each,vial,contains,500,mg,clarithromycin,as,clarithromycin,lactobionate., When, reconstituted, and, diluted, as, directed,, the, final, diluted, solution, contains, 2, mg/ml, of, clarithromycin, as, clarithromycin, lactobionate., For,the,full,list,of,excipients,,see,section,6.1. 3 PHARMACEUTICAL FORM Powder,for,concentrate,for,solution,for,infusion. White,to,off,white,cake,or,powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clarithromycin,is,indicated,in,adults,and,children,12,years,and,older. Clarithromycin,is,indicated,when,parenteral,therapy,is,required,for,treatment,of,infections,caused,by,susceptible,organisms,in, the,following,conditions,(see,sections,4.4,and,5.1); Acute,exacerbation,of,chronic,bronchitis Community,acquired,pneumonia Acute,bacterial,sinusitis,(adequately,diagnosed) Streptococcal,pharyngitis,and,tonsillitis Skin,and,soft,tissue,infections Consideration,should,be,given,to,official,guidance,on,the,appropriate,use,of,antibacterial,agents., 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Intravenous,therapy,may,be,given,for,2,to,5,days,in,the,very,ill,patient,and,should,be,changed,to,oral,clarithromycin,therapy, whenever,possible,as,determined,by,the,physician.,The,total,duration,of,treatment,with,clarithromycin,should,not,extend,14, days. _Adults_ The,recommended,dosage,of,Clarithromycin,500,mg,powder,for,concentrate,for,solution,for,infusion,is, Perskaitykite visą dokumentą